RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze

Coverage of IDE Clinical Trial Costs: Navigating the Medicare Maze

Posted 01 November 2011 | By Jeffrey D. Zigler, JD

Regulatory professionals recognize the value of clinical research in the medical device development process. The reward of obtaining third-party insurance coverage during a clinical trial is significant, but seeking such coverage by third-party payers has proven complex and confusing even for the most seasoned of professional teams.

 

© 2022 Regulatory Affairs Professionals Society.